{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:18:01Z","timestamp":1763414281563,"version":"3.45.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4\/7-13\/2019-NCD-II"],"award-info":[{"award-number":["5\/4\/7-13\/2019-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12010-025-05347-5","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:26:19Z","timestamp":1754461579000},"page":"6628-6639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elucidating the Role of MicroRNA 1827 as Diagnostic Biomarker in Prostate Cancer Progression"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-5196","authenticated-orcid":false,"given":"Anveshika","family":"Manoj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0349-5684","authenticated-orcid":false,"given":"Gautam","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-9403","authenticated-orcid":false,"given":"Durgesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-4563","authenticated-orcid":false,"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-9911","authenticated-orcid":false,"given":"Abbas Ali","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-411X","authenticated-orcid":false,"given":"Mohammad Kaleem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"3","key":"5347_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"6","key":"5347_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/iju.13593","volume":"25","author":"T Kimura","year":"2018","unstructured":"Kimura, T., & Egawa, S. (2018). Epidemiology of prostate cancer in Asian countries. International Journal of Urology, 25(6), 524\u2013531.","journal-title":"International Journal of Urology"},{"key":"5347_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canep.2017.12.002","volume":"52","author":"J Leal","year":"2018","unstructured":"Leal, J., Welton, N. J., Martin, R. M., Donovan, J., Hamdy, F., Neal, D., Noble, S., Lane, A., & Wolstenholme, J. (2018). Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study. Cancer Epidemiology, 52, 99\u2013105.","journal-title":"Cancer Epidemiology"},{"issue":"3","key":"5347_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/MED.0b013e328360332a","volume":"20","author":"L Klotz","year":"2013","unstructured":"Klotz, L. (2013). Prostate cancer overdiagnosis and overtreatment. Current Opinion in Endocrinology, Diabetes and Obesity, 20(3), 204\u2013209.","journal-title":"Current Opinion in Endocrinology, Diabetes and Obesity"},{"key":"5347_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40985-015-0012-1","volume":"36","author":"JL Bulliard","year":"2015","unstructured":"Bulliard, J. L., & Chiolero, A. (2015). Screening and overdiagnosis: Public health implications. Public Health Reviews,\n36, 1\u20135.","journal-title":"Public Health Reviews"},{"issue":"17","key":"5347_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A., & Andriole, G. L. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine,\n324(17), 1156\u20131161.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"5347_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajur.2018.11.007","volume":"6","author":"JL Descotes","year":"2019","unstructured":"Descotes, J. L. (2019). Diagnosis of prostate cancer. Asian Journal of Urology, 6(2), 129\u2013136.","journal-title":"Asian Journal of Urology"},{"issue":"1","key":"5347_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijrobp.2017.09.003","volume":"100","author":"PB Romesser","year":"2017","unstructured":"Romesser, P. B., Pei, X., Shi, W., Zhang, Z., Kollmeier, M., McBride, S. M., & Zelefsky, M. J. (2017). PSA bounce after dose-escalated external beam radiation therapy is an independent predictor of PSA recurrence, metastasis, and survival in prostate adenocarcinoma patients. International Journal of Radiation Oncology, Biology, Physics, 100(1), 59.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"5347_CR9","doi-asserted-by":"crossref","unstructured":"Manoj, A., Kumari, S., Prasad, G., & Ahmad, M. K. (2024). Computational analysis of differentially expressed circulating microRNA and identification of key genes in prostate cancer.\u00a0Indian Journal of Clinical Biochemistry, 1\u20138.","DOI":"10.1007\/s12291-024-01237-5"},{"key":"5347_CR10","doi-asserted-by":"publisher","first-page":"0129","DOI":"10.34133\/cbsystems.0129","volume":"5","author":"K Li","year":"2024","unstructured":"Li, K., Wang, Q., Tang, X., Akakuru, O. U., Li, R., Wang, Y., Zhang, R., Jiang, Z., & Yang, Z. (2024). Advances in prostate cancer biomarkers and probes. Cyborg and Bionic Systems, 5, 0129.","journal-title":"Cyborg and Bionic Systems"},{"key":"5347_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.25259\/Cytojournal_36_2024","volume":"21","author":"J Tao","year":"2024","unstructured":"Tao, J., Bian, X., Zhou, J., & Zhang, M. (2024). From microscopes to molecules: The evolution of prostate cancer diagnostics. CytoJournal, 21, 29.","journal-title":"CytoJournal"},{"issue":"10","key":"5347_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/1535370218775657","volume":"243","author":"AA Moustafa","year":"2018","unstructured":"Moustafa, A. A., Kim, H., Albeltagy, R. S., El-Habit, O. H., & Abdel-Mageed, A. B. (2018). MicroRNAs in prostate cancer: From function to biomarker discovery. Experimental Biology and Medicine, 243(10), 817\u2013825.","journal-title":"Experimental Biology and Medicine"},{"issue":"2","key":"5347_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/diseases11020077","volume":"11","author":"ZH Segherlou","year":"2023","unstructured":"Segherlou, Z. H., Saldarriaga, L., Azizi, E., Vo, K. A., Reddy, R., Siyanaki, M. R. H., & Lucke-Wold, B. (2023). MicroRNAs\u2019 role in diagnosis and treatment of subarachnoid hemorrhage. Diseases, 11(2), 77.","journal-title":"Diseases"},{"issue":"2","key":"5347_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.25259\/ijmr_2274_23","volume":"160","author":"A Manoj","year":"2024","unstructured":"Manoj, A., Ahmad, M. K., Kumar, M., Quayoom, S., Prasad, G., Kumar, D., & Mahdi, A. A. (2024). Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer. The Indian Journal of Medical Research,\n160(2), 236.","journal-title":"The Indian Journal of Medical Research"},{"key":"5347_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58207","author":"S Kumari","year":"2024","unstructured":"Kumari, S., Manoj, A., Rungta, S., Kumar, M., Prasad, G., Kumar, D., Mahdi, A. A., & Ahmad, M. K. (2024). Discovery and validation of novel microRNA panel for non-invasive prediction of prostate cancer. Cureus. https:\/\/doi.org\/10.7759\/cureus.58207","journal-title":"Cureus"},{"issue":"3","key":"5347_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.prnil.2023.06.002","volume":"11","author":"A Manoj","year":"2023","unstructured":"Manoj, A., Ahmad, M. K., Prasad, G., Kumar, D., Mahdi, A. A., & Kumar, M. (2023). Screening and validation of novel serum panel of microRNA in stratification of prostate cancer. Prostate International, 11(3), 150\u2013158.","journal-title":"Prostate International"},{"key":"5347_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12291-017-0731-9","volume":"34","author":"M Waseem","year":"2019","unstructured":"Waseem, M., Ahmad, M. K., Serajuddin, M., Bhaskar, V., Sankhwar, S. N., & Mahdi, A. A. (2019). MicroRNA-183-5p: A new potential marker for prostate cancer. Indian Journal of Clinical Biochemistry, 34, 207\u2013212.","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"5347_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.687576","volume":"8","author":"P Feng","year":"2021","unstructured":"Feng, P., Ge, Z., Guo, Z., Lin, L., & Yu, Q. (2021). A comprehensive analysis of the downregulation of miRNA-1827 and its prognostic significance by targeting SPTBN2 and BCL2L1 in ovarian cancer. Frontiers in Molecular Biosciences, 8, Article 687576.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"11","key":"5347_CR19","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1097\/MIB.0000000000000547","volume":"21","author":"C Polytarchou","year":"2015","unstructured":"Polytarchou, C., Oikonomopoulos, A., Mahurkar, S., Touroutoglou, A., Koukos, G., Hommes, D. W., & Iliopoulos, D. (2015). Assessment of circulating microRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology. Inflammatory Bowel Diseases, 21(11), 2533\u20132539.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"15","key":"5347_CR20","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1158\/0008-5472.CAN-10-4407","volume":"71","author":"F Xiong","year":"2011","unstructured":"Xiong, F., Wu, C., Chang, J., Yu, D., Xu, B., Yuan, P., Zhai, K., Xu, J., Tan, W., & Lin, D. (2011). Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Research, 71(15), 5175\u20135181.","journal-title":"Cancer Research"},{"issue":"2","key":"5347_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/jca.18188","volume":"9","author":"C San Ho","year":"2018","unstructured":"San Ho, C., Noor, S. M., & Nagoor, N. H. (2018). MiR-378 and MiR-1827 regulate tumor invasion, migration and angiogenesis in human lung adenocarcinoma by targeting RBX1 and CRKL, respectively. Journal of Cancer, 9(2), 331.","journal-title":"Journal of Cancer"},{"issue":"2","key":"5347_CR22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jcb.29402","volume":"121","author":"G Fan","year":"2020","unstructured":"Fan, G., Xu, P., & Tu, P. (2020). MiR-1827 functions as a tumor suppressor in lung adenocarcinoma by targeting MYC and FAM83F. Journal of Cellular Biochemistry,\n121(2), 1675\u20131689.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"5347_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-023-03133-z","volume":"23","author":"MS Sadeghi","year":"2023","unstructured":"Sadeghi, M. S., Lotfi, M., Soltani, N., Farmani, E., Fernandez, J. H. O., Akhlaghitehrani, S., Yasamineh, S., Kalajahi, H. G., & Gholizadeh, O. (2023). Recent advances on high-efficiency of microRNAs in different types of lung cancer: A comprehensive review. Cancer Cell International,\n23(1), 284.","journal-title":"Cancer Cell International"},{"issue":"8","key":"5347_CR24","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.18632\/oncotarget.7088","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang, C., Liu, J., Tan, C., Yue, X., Zhao, Y., Peng, J., Wang, X., Laddha, S. V., Chan, C. S., Zheng, S., & Feng, Z. (2016). MicroRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Oncotarget, 7(8), 8783.","journal-title":"Oncotarget"},{"issue":"2","key":"5347_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2022.13401","volume":"24","author":"M Hu","year":"2022","unstructured":"Hu, M., Ren, M., Zhao, Z., Cui, X., Shi, M., Yang, Y., & Guo, H. (2022). Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827. Oncology Letters, 24(2), 1\u201310.","journal-title":"Oncology Letters"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05347-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05347-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05347-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:05:51Z","timestamp":1763409951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05347-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5347"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05347-5","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"23 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of King George\u2019s Medical University (113th ECM II B-Ph.D\/P8) approved all experimental protocols involving human participants. Informed consent was received from all participants before enrollment. Written consent statements from patients who volunteered themselves were considered for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to Participate"}},{"value":"No individual person's data is used in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}